Five Perspectives from the Ivory Tower
This article was originally published in Start Up
Executive Summary
Start-Up and top academic scientists discuss how technology is leading discovery research strategies, where the bottlenecks are, and which new tools are being developed to overcome them. Start-Up conducted interviews with David Baltimore, Leroy Hood, Eric Lander, Robert Langer, and Phillip Sharp.
You may also be interested in...
Understanding How To Develop BTK Inhibitors In MS Is Evolving
Having a reversible BTK inhibitor in the multiple sclerosis armamentarium could be the best way to favorably impact the treatment landscape.
Science Matters: Setting The Stage For Using Wearables In Oncology Drug Development
Digital biomarkers using data collected with wearable devices are making their way into clinical trials, largely in cardiovascular, respiratory and rare disease settings around physical activity metrics.
Science Matters: Setting The Stage For Using Wearables In Oncology Drug Development
Digital biomarkers using data collected with wearable devices are making their way into clinical trials, largely in cardiovascular, respiratory and rare disease settings around physical activity metrics.